Your browser is no longer supported. Please, upgrade your browser.
Settings
PDLI PDL BioPharma, Inc. daily Stock Chart
PDLI [NASD]
PDL BioPharma, Inc.
Index- P/E- EPS (ttm)-0.42 Insider Own0.80% Shs Outstand143.70M Perf Week3.42%
Market Cap478.52M Forward P/E26.85 EPS next Y0.12 Insider Trans0.00% Shs Float143.25M Perf Month7.07%
Income-62.10M PEG- EPS next Q0.08 Inst Own87.80% Short Float11.29% Perf Quarter15.22%
Sales221.00M P/S2.17 EPS this Y84.10% Inst Trans0.24% Short Ratio9.36 Perf Half Y44.16%
Book/sh5.16 P/B0.65 EPS next Y123.10% ROA-5.90% Target Price3.00 Perf Year34.27%
Cash/sh2.79 P/C1.19 EPS next 5Y14.00% ROE-8.00% 52W Range2.25 - 3.31 Perf YTD14.83%
Dividend- P/FCF- EPS past 5Y-13.20% ROI11.90% 52W High0.76% Beta0.58
Dividend %- Quick Ratio10.60 Sales past 5Y-3.40% Gross Margin75.20% 52W Low48.00% ATR0.09
Employees14 Current Ratio10.90 Sales Q/Q8.30% Oper. Margin-22.10% RSI (14)64.17 Volatility3.20% 2.94%
OptionableYes Debt/Eq0.17 EPS Q/Q31.10% Profit Margin-28.40% Rel Volume0.63 Prev Close3.23
ShortableYes LT Debt/Eq0.17 EarningsMar 07 AMC Payout- Avg Volume1.73M Price3.33
Recom- SMA205.00% SMA509.52% SMA20022.99% Volume1,079,704 Change3.10%
Dec-22-16Resumed Piper Jaffray Overweight
Feb-23-16Reiterated RBC Capital Mkts Sector Perform $5 → $4
Feb-02-16Reiterated RBC Capital Mkts Sector Perform $6 → $5
Nov-05-15Reiterated RBC Capital Mkts Sector Perform $7 → $6
Oct-16-15Reiterated RBC Capital Mkts Sector Perform $8 → $7
Jan-20-11Upgrade RBC Capital Mkts Sector Perform → Outperform $6 → $6
Sep-10-10Initiated RBC Capital Mkts Sector Perform $6
Mar-27-09Upgrade Lazard Capital Mkts Hold → Buy $8
Mar-03-09Reiterated Wedbush Morgan Buy $15 → $9
Mar-03-09Reiterated JMP Securities Mkt Outperform $16 → $9
Jan-05-09Upgrade JP Morgan Underweight → Neutral
Dec-10-08Reiterated Credit Suisse Neutral $11 → $12
Sep-11-08Downgrade JP Morgan Neutral → Underweight
Jun-13-08Downgrade Credit Suisse Outperform → Neutral
May-12-08Reiterated Lehman Brothers Equal-Weight $16 → $12
Apr-22-08Downgrade Wachovia Outperform → Mkt Perform
Apr-11-08Reiterated Credit Suisse Outperform $19 → $16
Mar-10-08Downgrade Susquehanna Financial Positive → Neutral
Mar-06-08Reiterated BMO Capital Markets Market Perform $18 → $14
Mar-05-08Downgrade Lehman Brothers Overweight → Equal-weight $21 → $13
Dec-23-18 06:17AM  Hedge Funds Are Buying PDL BioPharma Inc. (PDLI) Insider Monkey
Dec-06-18 09:30AM  PDL BioPharma (PDLI) Up 2.4% Since Last Earnings Report: Can It Continue? Zacks
Nov-30-18 08:15AM  Report: Exploring Fundamental Drivers Behind Tesla, Nordson, Paycom Software, PDL BioPharma, Corcept Therapeutics, and Willis Towers Watson Public New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-26-18 09:00AM  Biotech and Cannabis Stocks to Watch ACCESSWIRE
Nov-20-18 01:52PM  Edited Transcript of PDLI earnings conference call or presentation 6-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-19-18 09:00AM  PDL BioPharma to Present at the 30th Annual Piper Jaffray Healthcare Conference PR Newswire
Nov-12-18 05:21PM  Brandes Investments' Top 4 Position Boosts in 3rd Quarter GuruFocus.com
Nov-08-18 11:01AM  PDL BioPharma (PDLI) Q3 Earnings Top, Revenues Rise, Stock Up Zacks
Nov-07-18 04:45PM  3 Health Care Stocks Rallying After US Midterms ACCESSWIRE +17.89%
Nov-06-18 05:52PM  PDL BioPharma: 3Q Earnings Snapshot Associated Press
04:05PM  PDL BioPharma Reports Third Quarter 2018 Financial Results PR Newswire
Oct-31-18 04:05PM  PDL BioPharma to Announce Third Quarter Financial Results on November 6, 2018 PR Newswire
Oct-23-18 07:45AM  Report: Exploring Fundamental Drivers Behind The Home Depot, uniQure N.V, Catalent, Apple, BioTime, and PDL BioPharma New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-08-18 09:00AM  PDL BioPharma Names Edward Imbrogno Vice President of Finance PR Newswire
Sep-26-18 09:00AM  PDL BioPharma to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference PR Newswire
Sep-24-18 09:00AM  PDL BioPharma Announces New $100 Million Stock Repurchase Program PR Newswire +6.17%
Sep-21-18 09:35AM  Is PDL BioPharma (PDLI) a Great Stock for Value Investors? Zacks
Sep-20-18 03:12PM  The 7 Best Biotech Stocks for Investors Who Hate Risk Kiplinger
08:30AM  SevenSaoi Capital Delivers Letter to the Board of PDL BioPharma PR Newswire
Sep-07-18 09:30AM  Why Is PDL BioPharma (PDLI) Up 2.5% Since Last Earnings Report? Zacks
Sep-05-18 06:00AM  3 Top Stocks Under $10 Motley Fool
Aug-30-18 08:00AM  PDL BioPharma to Present at the H.C. Wainwright 20th Annual Global Investment Conference PR Newswire
Aug-28-18 08:20AM  Report: Developing Opportunities within Parker Drilling, CoreLogic, Steven Madden, Diebold Nixdorf, Nevro, and PDL BioPharma Future Expectations, Projections Moving into 2018 GlobeNewswire
Aug-22-18 07:50PM  Edited Transcript of PDLI earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-18 11:48AM  PDL BioPharma (PDLI) Q2 Earnings Top, Revenues Slump Y/Y Zacks
Aug-08-18 04:56PM  PDL BioPharma: 2Q Earnings Snapshot Associated Press
04:05PM  PDL BioPharma Reports Second Quarter 2018 Financial Results PR Newswire
02:30PM  PDL BioPharma, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 04:02PM  PDL BioPharma Acquires Depomed's Remaining 50% Interest in Royalties and Milestones on Type 2 Diabetes Products PR Newswire
Aug-01-18 09:00AM  PDL BioPharma to Announce Second Quarter Financial Results on August 8, 2018 PR Newswire
Jul-18-18 07:45AM  Initiating Free Research Reports on Pieris Pharma and Three Other Biotech Equities ACCESSWIRE
Jul-04-18 09:40AM  Is PDL BioPharma (PDLI) a Great Stock for Value Investors? Zacks
Jun-26-18 07:40AM  Research Report Identifies PDL BioPharma, TEGNA, Patterson Companies, Boardwalk Pipeline Partners, Exact Sciences, and Berkshire Hathaway with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jun-22-18 09:00AM  Elizabeth O'Farrell Named to PDL BioPharma's Board of Directors PR Newswire
Jun-11-18 09:00AM  Shlomo Yanai Elected to PDL BioPharma's Board of Directors PR Newswire
Jun-06-18 03:26PM  4 Fixer Upper Stocks Poised to Bounce Back InvestorPlace
May-21-18 09:00AM  PDL BioPharma Names Dr. Jill Jene Vice President, Business Development PR Newswire
May-17-18 06:33AM  3 Top Stocks Under $5 Motley Fool
May-15-18 07:00AM  PDL BioPharma to Present at Two Upcoming Investor Conferences PR Newswire
May-12-18 01:47AM  Edited Transcript of PDLI earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-09-18 04:41PM  PDL BioPharma: 1Q Earnings Snapshot Associated Press
04:01PM  PDL BioPharma Announces First Quarter 2018 Financial Results PR Newswire
May-08-18 12:06PM  4 Penny Stocks to Own for 2018 InvestorPlace
08:30AM  Investor Expectations to Drive Momentum within Masco, Murphy Oil, NGL Energy Partners LP, PBF Energy, PDL BioPharma, and Phillips 66 Discovering Underlying Factors of Influence GlobeNewswire
May-02-18 07:00AM  PDL BioPharma to Announce First Quarter 2018 Financial Results on May 9, 2018 PR Newswire
Apr-16-18 07:00AM  PDL BioPharma to Hold Annual Meeting of Stockholders on June 8, 2018 PR Newswire
Apr-09-18 04:59PM  PDL BioPharma Shareholder, SevenSaoi Capital, Comments on the Nomination of Shlomo Yanai to the PDL Board of Directors and Delivers Letter to the Board Outlining Significant Concerns PR Newswire
Apr-03-18 04:02PM  PDL BioPharma to Present at the H.C. Wainwright Global Life Sciences Conference PR Newswire
Mar-31-18 10:02AM  Best-In-Class Undervalued Stocks Simply Wall St.
Mar-27-18 06:34AM  Is PDL BioPharma, Inc. a Buy? Motley Fool
Mar-20-18 11:43AM  Arena's (ARNA) Etrasimod Meets Phase II Colitis Study Goal Zacks
Mar-16-18 10:00AM  Is PDL BioPharma (PDLI) a Great Stock for Value Investors Right Now? Zacks
Mar-10-18 12:06AM  Edited Transcript of PDLI earnings conference call or presentation 8-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-09-18 09:44AM  PDL BioPharma (PDLI) Q4 Earnings Beat, Revenues Rise Y/Y Zacks +14.72%
Mar-08-18 04:40PM  PDL BioPharma posts 4Q profit Associated Press
04:02PM  PDL BioPharma Announces Fourth Quarter and Year End 2017 Financial Results PR Newswire
12:45PM  PDL BioPharma, Inc. to Host Earnings Call ACCESSWIRE
06:19AM  Will PDL BioPharma Inc (NASDAQ:PDLI) Continue To Underperform Its Industry? Simply Wall St.
Mar-07-18 07:45AM  Report: Developing Opportunities within Seattle Genetics, PBF Energy, Chipotle Mexican Grill, CIT Group Inc (DEL), PDL BioPharma, and Dollar General Future Expectations, Projections Moving into 2018 GlobeNewswire
Mar-02-18 02:12PM  The Week Ahead In Biotech: Earnings, PDUFA Dates And More Benzinga
Mar-01-18 07:00AM  PDL BioPharma to Announce Fourth Quarter / Year-End 2017 Financial Results on March 8, 2018 PR Newswire
Feb-26-18 11:16AM  Richard L. Lindstrom, M.D. Joins LENSAR, Inc. Board of Directors Business Wire
Feb-21-18 06:08AM  Is PDL BioPharma Inc (NASDAQ:PDLI) A Buy At Its Current PE Ratio? Simply Wall St.
Feb-20-18 09:56AM  Neos Therapeutics Reiterates Confidence in Strategic Plan and Value Creation Opportunities PR Newswire
07:00AM  PDL BioPharma Terminates Interest in Pursuing Acquisition of Neos PR Newswire
Feb-14-18 07:00AM  PDL BioPharma to Present at Two Upcoming Investor Conferences PR Newswire
06:32AM  3 Cheapest Healthcare Stocks on the Market Right Now Motley Fool
Feb-08-18 06:04AM  What Are the Best Healthcare Stocks to Buy? Here Are a Top AI System's 5 Favorites Motley Fool -9.81%
Dec-25-17 12:17PM  ETFs with exposure to PDL BioPharma, Inc. : December 25, 2017 Capital Cube
Dec-20-17 08:53AM  PDL BioPharma, Inc. (PDLI) Jumps: Stock Rises 8.2% Zacks
Dec-18-17 08:39AM  PDL BioPharma, Inc. (PDLI) Jumps: Stock Rises 8.2% Zacks
Dec-13-17 01:51PM  ETFs with exposure to PDL BioPharma, Inc. : December 13, 2017 Capital Cube
Dec-12-17 10:12AM  PDL BioPharma, Inc. :PDLI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 12, 2017 Capital Cube
Nov-15-17 10:36AM  Noden Pharma Announces FDA Approval of Tekturna®(aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older PR Newswire
Nov-13-17 09:25AM  AstraZeneca Gets Positive CHMP Opinion for Asthma Candidate Zacks
Nov-10-17 09:04AM  Puma (PBYI) Falls Despite Narrower-Than-Expected Q3 Loss Zacks
Nov-09-17 08:20AM  Factors of Influence in 2018, Key Indicators and Opportunity within Tegna, Inpixon, Honeywell International, Nektar, PDL Biopharma, and Innoviva New Research Emphasizes Economic Growth GlobeNewswire
Nov-08-17 08:00AM  PDL BioPharma's Proposal to Acquire Neos Therapeutics Expires Today; PDL Urges Neos to Provide Update on Sale Process PR Newswire
06:00AM  Why Neos Therapeutics Inc Rose 13.7% In October Motley Fool
Nov-07-17 04:02PM  PDL BioPharma to Present at Two Upcoming Investor Conferences PR Newswire
Nov-03-17 12:47PM  PDL BioPharma (PDLI) Q3 Earnings Beat, Revenues Rise Y/Y Zacks
12:01AM  Edited Transcript of PDLI earnings conference call or presentation 2-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-02-17 05:47PM  PDL BioPharma posts 3Q profit Associated Press
04:02PM  PDL BioPharma Announces Third Quarter 2017 Financial Results PR Newswire
11:10AM  PDL BioPharma, Inc. to Host Earnings Call ACCESSWIRE
Oct-31-17 03:36PM  Neos Therapeutics to consider other offers after PDL snub -sources Reuters
Oct-30-17 04:38PM  PDL BioPharma Issues Statement in Response to Neos Therapeutics Rejection of PDL Acquisition Proposal PR Newswire
08:48AM  Neos Therapeutics' stock falls after rejecting PDL BioPharma's buyout bid MarketWatch
08:30AM  Neos Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from PDL BioPharma PR Newswire
07:00AM  PDL BioPharma Announces Settlement Agreement with Valeant PR Newswire
Oct-27-17 11:40AM  PDL BioPharma, Inc. Value Analysis (NASDAQ:PDLI) : October 27, 2017 Capital Cube
Oct-26-17 01:34PM  Why Neos Therapeutics Inc (NEOS) Shares Climbed 37% Today SmarterAnalyst -7.50%
10:45AM  Neos Therapeutics Stock Soars on 3rd Unsolicited Buyout Offer From PDL BioPharma TheStreet.com
10:33AM  Neos Therapeutics' stock rockets after buyout bid, says it will respond in 'due course' MarketWatch
10:01AM  Neos Therapeutics to Review Unsolicited Proposal from PDL BioPharma PR Newswire
08:50AM  PDL BioPharma makes unsolicited bid to buy Neos Therapeutics for a 40% premium MarketWatch
08:30AM  PDL BioPharma Proposes to Acquire Neos Therapeutics for $10.25 per Share in Cash PR Newswire
08:19AM  PDL BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : PDLI-US : October 26, 2017 Capital Cube
Oct-25-17 04:45PM  PDL BioPharma to Announce Third Quarter 2017 Financial Results on November 2, 2017 PR Newswire
Oct-20-17 10:22AM  ETFs with exposure to PDL BioPharma, Inc. : October 20, 2017 Capital Cube
PDL BioPharma, Inc. acquires and manages companies, products, royalty agreements, and debt facilities in the biotechnology, pharmaceutical, and medical device industries in the United States, Europe, and internationally. The company operates in three segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of notes and other long-term receivables; royalty rights and hybrid notes/royalty receivables; equity investments in healthcare companies; and royalties from issued patents covering the humanization of antibodies, including Avastin, Herceptin, Xolair, Lucentis, Perjeta, Kadcyla, and Tysabri. The Pharmaceutical segment manufactures, markets, and sells prescription medicine products for the treatment of hypertension to wholesalers under the Tekturna and Tekturna HCT names in the United States, as well as under the Rasilez and Rasilez HCT names internationally. The Medical Devices segment manufactures and sells LENSAR laser systems for anterior capsulotomy, lens fragmentation, corneal and arcuate incisions to ophthalmic ambulatory surgical centers, specialty ophthalmic hospitals, and multi-specialty hospitals through a direct sales force. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.